Skip to main content

Entrepreneurship for All

Diversify SBIR

At the NCI SBIR Development Center, we believe that diverse perspectives lead to creative solutions.

The mission of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs includes fostering and encouraging women and socially or economically disadvantaged persons to participate in innovation and entrepreneurship. Applicants can self-identify during the application process.

Women-owned Small Business

  • The firm must be at least 51% owned and controlled by one or more women and be primarily managed by one or more women.
  • The firm must have no more than 500 employees, including affiliates.
  • The company must be owned by U.S. citizens.

Socially and Economically Disadvantaged Small Business

  • The firm must be 51% or more owned and control by one or more socially disadvantaged and economically disadvantaged persons.

  • The firm must have no more than 500 employees, including affiliates.
  • The company must be owned by U.S. citizens.

State Recipient States of the NIH Institutional Development Award (IDeA)

The IDeA program builds research capacities in states that historically have had low levels of NIH funding by supporting basic, clinical, and translational research; faculty development; and infrastructure improvements. See below for the full list of IDeA states.

Alaska

Arkansas

Delaware

Hawaii

Idaho

Kansas

Kentucky

Louisiana

Maine

Mississippi

Montana

Nebraska

Nevada

New Hampshire

New Mexico

North Dakota

Oklahoma

Rhode Island

South Carolina

South Dakota

Vermont

West Virginia

Wyoming

Puerto Rico

 

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Entrepreneurship for All was originally published by the National Cancer Institute.”